GBinsight is a comprehensive and targeted next-generation DNA sequencing (NGS) assay designed to analyze the genetic architecture of complex diseases. Combined with a novel state-of-the-art bioinformatics analysis algorithm, GBinsight genetic testing and analysis promises to help scientists and clinicians gain genetic insights of common metabolic diseases and facilitate research on personalized prevention and medical intervention strategies.
GB HealthWatch, a nutritional genomics and digital health company, has been awarded a Phase I Small Business Innovative Research (SBIR) Grant from the National Institutes of Health (NIH) to develop a mobile application that delivers personalized nutritional recommendations in the form of meal plans to those who are genetically susceptible to Alzheimer's disease (AD). There is no cure for AD and disease pathogenesis begins decades before symptoms appear; therefore, adopting the right dietary and lifestyle ch
GB HealthWatch, a San Diego-based digital health company, launches the latest version of the HealthWatch 360 mobile app for personalized nutrition and disease prevention.
GB HealthWatch, a San Diego-based digital health and nutritional genomics company, announces the release of a new version of the nutrition scoring system integrated in their popular mobile app, HealthWatch 360. The update positions HealthWatch 360 to be the first nutrition app fully aligned with the Dietary Guidelines for Americans 2015.